P1469: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK OFF-TREATMENT PERIOD (WASHOUT) IN THE PHASE 3 CADENZA STUDY

• Alexander Röth,
• Sigbjørn Berentsen,
• Wilma Barcellini,
• Shirley D’sa,
• Bernd Jilma,
• Marc Michel,
• Ilene C Weitz,
• Masaki Yamaguchi,
• Jun-Ichi Nishimura,
• Josephine Vos,
• Joan Cid,
• Michael Storek,
• Nancy Wong,
• Ronnie Yoo,
• Deepthi Jayawardene,
• Katarina Kralova,
• Marek Wardęcki,
• Frank Shafer,
• Michelle Lee,
• Catherine M Broome

Affiliations

Alexander Röth

1 West German Cancer Center, University Hospital Essen, University of Duisberg-Essen, Department of Hematology and Stem Cell Transplantation, Essen, Germany

Sigbjørn Berentsen

2 Department of Research and Innovation, Haugesund Hospital, Haugesund, Norway

Wilma Barcellini

3 Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy

Shirley D’sa

4 University College London Hospitals Nhs Foundation Trust, UCLH Centre for Waldenström’s Macroglobulinemia and Related Conditions, London, United Kingdom

Bernd Jilma

5 Medical University of Vienna, Department of Clinical Pharmacology, Vienna, Austria

Marc Michel

6 Henri-Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, UPEC, Créteil, France

Ilene C Weitz

7 Keck School of Medicine of USC, Los Angeles, United States

Masaki Yamaguchi

8 Ishikawa Prefectural Central Hospital, Kanazawa, Japan

Jun-Ichi Nishimura

9 Graduate School of Medicine and Faculty of Medicine, Osaka University, Suita, Japan

Josephine Vos

10 Amsterdam UMC, University of Amsterdam & Sanquin, Amsterdam, The Netherlands

Joan Cid

11 ICMHO, IDIBAPS, Hospital Clinic, Department of Hemotherapy and Hemostasis, Barcelona, Spain

Michael Storek

12 Sanofi, Cambridge, Massachusetts, United States

Nancy Wong

12 Sanofi, Cambridge, Massachusetts, United States

Ronnie Yoo

12 Sanofi, Cambridge, Massachusetts, United States

Deepthi Jayawardene

12 Sanofi, Cambridge, Massachusetts, United States

Katarina Kralova

13 Sanofi, Paris, France

Marek Wardęcki

14 Sanofi, Warsaw, Poland

Frank Shafer

15 Sanofi, Bridgewater, United States

Michelle Lee

15 Sanofi, Bridgewater, United States

Catherine M Broome

16 MedStar Georgetown University Hospital, Division of Hematology, Washington, United States